Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-820836 in Healthy Subjects.

Trial Profile

Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-820836 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2015

At a glance

  • Drugs Liafensine (Primary)
  • Indications Depressive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Planned end date changed from 1 Sep 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov..
    • 02 Apr 2010 Planned end date changed from 1 Mar 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top